JOHN OYLER, the Chief Executive Officer of $BGNE, sold 11,195 shares of the company on 03-03-2025 for an estimated $2,725,326. We received data on the trade from a recent SEC filing. This was a sale of approximately 15.3% of their shares of this class of stock. Following this trade, they now own 61,841 shares of this class of $BGNE stock.
$BGNE Insider Trading Activity
$BGNE insiders have traded $BGNE stock on the open market 89 times in the past 6 months. Of those trades, 0 have been purchases and 89 have been sales.
Here’s a breakdown of recent trading of $BGNE stock by insiders over the last 6 months:
- ADVISORS, LTD. HHLR sold 17,842,500 shares for an estimated $3,568,500,000
- BROS. ADVISORS LP BAKER has made 0 purchases and 4 sales selling 1,037,017 shares for an estimated $194,200,043.
- XIAODONG WANG has made 0 purchases and 39 sales selling 173,631 shares for an estimated $33,791,145.
- JOHN OYLER (Chief Executive Officer) has made 0 purchases and 26 sales selling 117,175 shares for an estimated $28,430,730.
- XIAOBIN WU (President, COO & GM China) has made 0 purchases and 7 sales selling 56,921 shares for an estimated $13,485,659.
- LAI WANG (Global Head of R&D) has made 0 purchases and 7 sales selling 10,000 shares for an estimated $2,387,948.
- CHAN HENRY LEE (SVP, General Counsel) has made 0 purchases and 5 sales selling 3,609 shares for an estimated $926,538.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BGNE Hedge Fund Activity
We have seen 107 institutional investors add shares of $BGNE stock to their portfolio, and 128 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HHLR ADVISORS, LTD. removed 1,372,500 shares (-26.5%) from their portfolio in Q4 2024, for an estimated $253,514,475
- BAKER BROS. ADVISORS LP removed 1,037,017 shares (-9.8%) from their portfolio in Q4 2024, for an estimated $191,547,410
- TEMASEK HOLDINGS (PRIVATE) LTD removed 863,247 shares (-36.1%) from their portfolio in Q4 2024, for an estimated $159,450,353
- POINT72 ASSET MANAGEMENT, L.P. removed 642,000 shares (-96.2%) from their portfolio in Q4 2024, for an estimated $118,583,820
- MORGAN STANLEY added 565,108 shares (+326.6%) to their portfolio in Q4 2024, for an estimated $104,381,098
- PARADIGM BIOCAPITAL ADVISORS LP added 415,688 shares (+207.5%) to their portfolio in Q4 2024, for an estimated $76,781,730
- VESTAL POINT CAPITAL, LP removed 350,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $78,578,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
